Qube Research & Technologies (QRT)
MGNX icon

Qube Research & Technologies (QRT)’s MacroGenics MGNX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-187,464
Closed -$542K – 3846
2026
Q1 		$542K Buy
+187,464
New +$400K ﹤0.01% 2714
2025
Q4 		– Sell
-22,415
Closed -$37.7K – 3920
2025
Q3 		$37.7K Buy
+22,415
New +$36.3K ﹤0.01% 3221
2024
Q2 		– Sell
-246,483
Closed -$3.63M – 4388
2024
Q1 		$3.63M Buy
246,483
+215,937
+707% +$3.26M 0.01% 1409
2023
Q4 		$294K Buy
+30,546
New +$211K ﹤0.01% 2592
2022
Q3 		– Sell
-176,710
Closed -$521K – 2813
2022
Q2 		$521K Buy
176,710
+121,160
+218% +$637K ﹤0.01% 1390
2022
Q1 		$489K Buy
55,550
+25,788
+87% +$285K ﹤0.01% 1538
2021
Q4 		$478K Buy
29,762
+9,582
+47% +$180K ﹤0.01% 1597
2021
Q3 		$423K Buy
+20,180
New +$486K 0.01% 1298

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MGNX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 187,464 shares — an estimated $542K sold.

Qube Research & Technologies (QRT) first reported a position in MGNX in Q3 2021 and held it in 8 quarters. The position peaked at $3.63M in Q1 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 187,464 MacroGenics shares in Q2 2026, an estimated $542K.
  • Qube Research & Technologies (QRT) first reported a position in MacroGenics in Q3 2021 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s MacroGenics position peaked at $3.63M in Q1 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.